Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Aminolevulinic acid
Drug ID BADD_D00110
Description A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
Indications and Usage Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.
Marketing Status Prescription
ATC Code L01XD04
DrugBank ID DB00855
KEGG ID D07567
MeSH ID D000622
PubChem ID 137
TTD Drug ID D0Y7ZD
NDC Product Code 46016-5450
Synonyms Aminolevulinic Acid | Acid, Aminolevulinic | Delta-Aminolevulinic Acid | Acid, Delta-Aminolevulinic | Delta Aminolevulinic Acid | Levulan | 5-Aminolaevulinate | 5 Aminolaevulinate | 5-Aminolevulinate | 5 Aminolevulinate | Aminolevulinic Acid Hydrochloride | Acid Hydrochloride, Aminolevulinic | Hydrochloride, Aminolevulinic Acid
Chemical Information
Molecular Formula C5H9NO3
CAS Registry Number 106-60-5
SMILES C(CC(=O)O)C(=O)CN
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Skin disorder23.03.03.007--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin hyperpigmentation23.05.01.003--
Skin hypertrophy23.01.04.002--Not Available
Sunburn12.05.02.001; 23.03.09.007--Not Available
Swelling face10.01.05.018; 23.04.01.0180.000533%Not Available
Tenderness08.01.08.005--Not Available
Tension19.06.02.005--Not Available
Thrombocytopenia01.08.01.002--Not Available
Transient ischaemic attack17.08.04.001; 24.04.06.0050.000533%
Type I hypersensitivity10.01.03.0060.000533%Not Available
Ulcer08.03.06.001--Not Available
Urticaria10.01.06.001; 23.04.02.0010.000533%
Vision blurred06.02.06.007; 17.17.01.0100.000533%
Vomiting07.01.07.0030.000533%
Wound secretion08.01.03.035; 12.01.08.007--Not Available
Brain oedema12.01.10.010; 17.07.02.003--
Excoriation12.01.06.007; 23.03.11.003--Not Available
Skin tightness23.03.03.018--Not Available
Photodermatosis23.03.09.004--Not Available
Lymphatic disorder01.09.01.003--Not Available
Haemorrhage24.07.01.002--Not Available
Angiopathy24.03.02.007--Not Available
Induration08.01.03.020--Not Available
Brain neoplasm16.30.01.003; 17.20.01.003--Not Available
Cardiac disorder02.01.01.003--Not Available
Embolism24.01.01.009--
Infestation11.09.01.001; 23.09.05.001--Not Available
Mental disorder19.07.01.002--Not Available
Blood disorder01.05.01.004--Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene